ClinVar Miner

Submissions for variant NM_000238.4(KCNH2):c.2182A>T (p.Ile728Phe)

dbSNP: rs199473533
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003647742 SCV004467280 uncertain significance Long QT syndrome 2023-04-19 criteria provided, single submitter clinical testing This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of long QT syndrome (PMID: 19716085). ClinVar contains an entry for this variant (Variation ID: 67373). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 728 of the KCNH2 protein (p.Ile728Phe).
All of Us Research Program, National Institutes of Health RCV003647742 SCV004835337 uncertain significance Long QT syndrome 2023-11-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV004017369 SCV004849033 uncertain significance Cardiovascular phenotype 2017-12-28 criteria provided, single submitter clinical testing The c.2182A>T (p.I728F) alteration is located in exon 9 (coding exon 9) of the KCNH2 gene. This alteration results from a A to T substitution at nucleotide position 2182, causing the isoleucine (I) at amino acid position 728 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
GeneDx RCV004719690 SCV005325353 uncertain significance not provided 2024-01-26 criteria provided, single submitter clinical testing Reported in two patients with long QT syndrome in published literature (PMID: 19716085); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19716085)
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust RCV000058093 SCV000089613 not provided Congenital long QT syndrome no assertion provided literature only This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.